Searched for
TORRENT PHARMA SHARE BLOCK DEAL
Fidelity Investments buys 2 pc stake in Lodha Developers for Rs 1,864 croreFidelity Investments has strategically acquired a 2% stake in Lodha Developers, amounting to Rs 1,864 crore, through open market operations...- Trump's former national security adviser John Bolton pleads guilty in classified records caseFormer Trump national security adviser John Bolton has pleaded guilty to illegally retaining classified information. This plea agreement wi...
- Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
- HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 croreHDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder...
- Stock Radar: Torrent Power stock showing signs of bottoming out after falling 20% from April 2026 highsTorrent Power shares are showing signs of a comeback after a significant dip, with bulls attempting to regain control. Experts suggest a bu...
- Vedanta may have a couple more tranches of promoter-driven selling; stock likely to bounce back in 1-2 weeks: Ambareesh BaligaVedanta shares saw a significant drop following a large block deal, but analysts suggest the selloff is temporary. Promoter entity Twin Sta...
- Stocks in news: Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, Tata MotorsIndian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRC...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Promoter Twin Star sells Vedanta shares worth Rs 1,896 crore in block dealTwin Star Holdings, a promoter entity of Vedanta, sold 6.51 crore shares worth nearly Rs 1,896 crore through a block deal on Tuesday. The t...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Vedanta Power, Oil & Gas, and Iron shares rally up to 5%; Aluminium sheds 3%. Should you buy, sell or hold?Vedanta’s newly demerged entities extended their rally, with Oil & Gas, Power and Iron & Steel hitting upper circuits, while Aluminium slip...
- Vedanta shares fall 6% after Rs 2,149 crore block deal; promoter Twin Star likely sellerVedanta's stock experienced a significant dip, dropping up to 6% from its intraday peak of Rs 287. This decline followed media speculation ...
- Block deal alert! Craftsman Auto shares in focus as promoter to sell stake worth Rs 486 croreCraftsman Automation shares are under scrutiny as promoter Srinivasan Ravi plans to sell up to 2.01% stake via a block deal worth Rs 486 cr...
- Stocks in news: TCS, JSW Infra, Craftsman Automation, IIFL Finance, Transrail LightingIndian markets showed a positive trend on Monday, recovering some of Friday's dips, buoyed by global sentiment and strong performance in th...
- Sensex rises 291 points, Nifty closes above 24,100; Tech Mahindra, Sun Pharma among top gainersIndian stock markets saw a positive start on Monday, with Sensex and Nifty inching up after Friday's dip. Tech Mahindra led the gains, whil...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
Load More
